Stefani Wolff, Chief Development Officer at Principia Biopharma Inc. (PRNB), sold 10,508 shares at $60.81 ($639K) on 2020-06-15, disclosed to the SEC on 2020-06-17.
Open-market sale of $639k PRNB by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.89 | 400 | $24K | 3.8% |
| 2 | $60.81 | 5,004 | $304K | 47.6% |
| 3 | $60.81 | 5,004 | $304K | 47.6% |
| 4 | $61.37 | 100 | $6K | 1.0% |
| Total | $60.78 avg | 10,508 | $639K | 100% |
| Filing → |
| NRIX | SELL | 2022-11-01 | $5K | — | Filing → |
| NRIX | SELL | 2022-08-02 | $6K | — | Filing → |
| NRIX | SELL | 2022-05-03 | $4K | — | Filing → |